Yeh RW - Search Results

1

Days at home after transcatheter or surgical aortic valve replacement in high-risk patients.

Chung M, Butala NM, Faridi KF, Almarzooq ZI, Liu D, Xu J, Song Y, Baron SJ, Shen C, Kazi DS, Yeh RW. Chung M, et al. Among authors: yeh rw. Am Heart J. 2023 Jan;255:125-136. doi: 10.1016/j.ahj.2022.10.080. Epub 2022 Oct 27. Am Heart J. 2023. PMID: 36309128

2

Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.

Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Foo SY, et al. Among authors: yeh rw. Am Heart J. 2006 Aug;152(2):290.e1-7. doi: 10.1016/j.ahj.2006.04.028. Am Heart J. 2006. PMID: 16875910

3

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.

Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK. Cruz-Gonzalez I, et al. Among authors: yeh rw. J Thromb Thrombolysis. 2008 Apr;25(2):214-8. doi: 10.1007/s11239-007-0071-3. Epub 2007 Jul 15. J Thromb Thrombolysis. 2008. PMID: 17632689

4

Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.

Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Baron SJ, et al. Among authors: yeh rw. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):116-20. doi: 10.1002/ccd.21595. Catheter Cardiovasc Interv. 2008. PMID: 18546237

5

What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?

Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, Watanabe H, Baron SJ, Healy JL, Yeh RW, Jang IK. Cruz-Gonzalez I, et al. Among authors: yeh rw. Blood Coagul Fibrinolysis. 2008 Jul;19(5):401-4. doi: 10.1097/MBC.0b013e328304e00d. Blood Coagul Fibrinolysis. 2008. PMID: 18600089

6

Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes.

Yeh RW, Baron SJ, Healy JL, Pomerantsev E, McNulty IA, Cruz-Gonzalez I, Jang IK. Yeh RW, et al. Catheter Cardiovasc Interv. 2009 Aug 1;74(2):359-64. doi: 10.1002/ccd.21999. Catheter Cardiovasc Interv. 2009. PMID: 19213062

7

Caesarian dissection: a case of chest pain and dyspnea during delivery.

Mauer AC, Baron SJ, Yeh RW, Scott NS. Mauer AC, et al. Among authors: yeh rw. Circulation. 2013 Apr 9;127(14):1530-5. doi: 10.1161/CIRCULATIONAHA.112.000858. Circulation. 2013. PMID: 23569120 No abstract available.

8

The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes.

Baron SJ, Yeh RW, Cohen DJ. Baron SJ, et al. Among authors: yeh rw. Circulation. 2014 Oct 14;130(16):1343-5. doi: 10.1161/CIRCULATIONAHA.114.012640. Epub 2014 Sep 4. Circulation. 2014. PMID: 25189216 No abstract available.

9

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.

Secemsky EA, Butala NM, Kartoun U, Mahmood S, Wasfy JH, Kennedy KF, Shaw SY, Yeh RW. Secemsky EA, et al. Among authors: yeh rw. J Am Heart Assoc. 2016 Oct 17;5(10):e004310. doi: 10.1161/JAHA.116.004310. J Am Heart Assoc. 2016. PMID: 27792650 Free PMC article.

10

Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.

Young MN, Elmariah S, Kennedy KF, Inglessis I, Yeh RW. Young MN, et al. Among authors: yeh rw. Catheter Cardiovasc Interv. 2017 Nov 1;90(5):830-838. doi: 10.1002/ccd.27018. Epub 2017 Mar 22. Catheter Cardiovasc Interv. 2017. PMID: 28326675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page